Clinical Trial Update: Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether the probiotic Clostridium butyricum can alleviate anxiety and depression in patients with functional dyspepsia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Functional Dyspepsia
• Major Depressive Disorder

Drugs mentioned

• Clostridium butyricum (Clostridium butyricum)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Functional Dyspepsia, Probiotics | Phase 4 | Status: RECRUITING